Cerevance is a private pharmaceutical company focused on central nervous system diseases. The company’s strengths include its powerful NETSseq target discovery platform, a large collection of human brain tissue samples, a pipeline of novel discovery-stage and clinical-stage compounds and a team with a proven track record. Its scientists believe that they are well positioned to deliver life-changing therapeutics for patients who have brain-related disorders.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
CVN424 for Parkinson's Disease
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):